Annie Neild
Algemeen Adviseur bij FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Profiel
Annie Neild is currently the Executive VP & Head-Global Regulatory Affairs at NewAmsterdam Pharma Co. NV.
Previously, she worked as the Head-Regulatory Affairs at Corvidia Therapeutics, Inc. in 2020.
Ms. Neild holds a doctorate degree from Yale University.
Actieve functies van Annie Neild
| Bedrijven | Functie | Begin |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Algemeen Adviseur | 01-03-2021 |
Eerdere bekende functies van Annie Neild
| Bedrijven | Functie | Einde |
|---|---|---|
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Algemeen Adviseur | 01-07-2020 |
Opleiding van Annie Neild
| Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
